Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice

Jianguo Xu, Charles R. Woods, Ana L. Mora, Robert Joodi, Kenneth L. Brigham, Smita Iyer, Mauricio Rojas

Research output: Contribution to journalArticle

258 Citations (Scopus)

Abstract

Bone marrow-derived mesenchymal stem cells (BMDMSCs) appear to be important in repair of the chronic lung injury caused by bleomycin in mice. To determine effects of these BMDMSCs on an acute inflammatory response, we injected C57BL/6 mice intraperitoneally with 1 mg/kg endotoxin followed either by intravenous infusion of 5 × 105 BMDMSCs, the same number of lung fibroblasts, or an equal volume of normal saline solution. Lungs harvested 6, 24, and 48 h and 14 days after endotoxin showed that BMDMSC administration prevented endotoxin-induced lung inflammation, injury, and edema. Although we were able to detect donor cells in the lungs at 1 day after endotoxin, by 14 days no donor cells were detected. BMDMSC administration suppressed the endotoxin-induced increase in circulating proinflammatory cytokines without decreasing circulating levels of anti-inflammatory mediators. Ex vivo cocultures of BMDMSC and lung cells from endotoxemic animals demonstrated a bilateral conversation in which lung cells stimulated proliferation and migration of stem cells and suppressed proinflammatory cytokine production by lung cells. We conclude that BMDMSCs decrease both the systemic and local inflammatory responses induced by endotoxin. These effects do not require either lung engraftment or differentiation of the stem cells and are due at least in part to the production of stem cell chemoattractants by the lungs and to humoral and physical interactions between stem cells and lung cells. We speculate that mobilization of this population of BMDMSCs may be a general mechanism for modulating an acute inflammatory response.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume293
Issue number1
DOIs
StatePublished - Jul 1 2007
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Endotoxins
Bone Marrow
Lung
Stem Cells
Lung Injury
Cytokines
Chemotactic Factors
Coculture Techniques
Inbred C57BL Mouse
Intravenous Infusions
Sodium Chloride
Cell Movement
Edema
Pneumonia
Anti-Inflammatory Agents
Fibroblasts
Cell Count
Cell Proliferation
Population

Keywords

  • Lipopolysaccharide
  • Lung injury

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. / Xu, Jianguo; Woods, Charles R.; Mora, Ana L.; Joodi, Robert; Brigham, Kenneth L.; Iyer, Smita; Rojas, Mauricio.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 293, No. 1, 01.07.2007.

Research output: Contribution to journalArticle

Xu, Jianguo ; Woods, Charles R. ; Mora, Ana L. ; Joodi, Robert ; Brigham, Kenneth L. ; Iyer, Smita ; Rojas, Mauricio. / Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2007 ; Vol. 293, No. 1.
@article{35dca2aad3134107a2bc637ab1461025,
title = "Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice",
abstract = "Bone marrow-derived mesenchymal stem cells (BMDMSCs) appear to be important in repair of the chronic lung injury caused by bleomycin in mice. To determine effects of these BMDMSCs on an acute inflammatory response, we injected C57BL/6 mice intraperitoneally with 1 mg/kg endotoxin followed either by intravenous infusion of 5 × 105 BMDMSCs, the same number of lung fibroblasts, or an equal volume of normal saline solution. Lungs harvested 6, 24, and 48 h and 14 days after endotoxin showed that BMDMSC administration prevented endotoxin-induced lung inflammation, injury, and edema. Although we were able to detect donor cells in the lungs at 1 day after endotoxin, by 14 days no donor cells were detected. BMDMSC administration suppressed the endotoxin-induced increase in circulating proinflammatory cytokines without decreasing circulating levels of anti-inflammatory mediators. Ex vivo cocultures of BMDMSC and lung cells from endotoxemic animals demonstrated a bilateral conversation in which lung cells stimulated proliferation and migration of stem cells and suppressed proinflammatory cytokine production by lung cells. We conclude that BMDMSCs decrease both the systemic and local inflammatory responses induced by endotoxin. These effects do not require either lung engraftment or differentiation of the stem cells and are due at least in part to the production of stem cell chemoattractants by the lungs and to humoral and physical interactions between stem cells and lung cells. We speculate that mobilization of this population of BMDMSCs may be a general mechanism for modulating an acute inflammatory response.",
keywords = "Lipopolysaccharide, Lung injury",
author = "Jianguo Xu and Woods, {Charles R.} and Mora, {Ana L.} and Robert Joodi and Brigham, {Kenneth L.} and Smita Iyer and Mauricio Rojas",
year = "2007",
month = "7",
day = "1",
doi = "10.1152/ajplung.00431.2006",
language = "English (US)",
volume = "293",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice

AU - Xu, Jianguo

AU - Woods, Charles R.

AU - Mora, Ana L.

AU - Joodi, Robert

AU - Brigham, Kenneth L.

AU - Iyer, Smita

AU - Rojas, Mauricio

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Bone marrow-derived mesenchymal stem cells (BMDMSCs) appear to be important in repair of the chronic lung injury caused by bleomycin in mice. To determine effects of these BMDMSCs on an acute inflammatory response, we injected C57BL/6 mice intraperitoneally with 1 mg/kg endotoxin followed either by intravenous infusion of 5 × 105 BMDMSCs, the same number of lung fibroblasts, or an equal volume of normal saline solution. Lungs harvested 6, 24, and 48 h and 14 days after endotoxin showed that BMDMSC administration prevented endotoxin-induced lung inflammation, injury, and edema. Although we were able to detect donor cells in the lungs at 1 day after endotoxin, by 14 days no donor cells were detected. BMDMSC administration suppressed the endotoxin-induced increase in circulating proinflammatory cytokines without decreasing circulating levels of anti-inflammatory mediators. Ex vivo cocultures of BMDMSC and lung cells from endotoxemic animals demonstrated a bilateral conversation in which lung cells stimulated proliferation and migration of stem cells and suppressed proinflammatory cytokine production by lung cells. We conclude that BMDMSCs decrease both the systemic and local inflammatory responses induced by endotoxin. These effects do not require either lung engraftment or differentiation of the stem cells and are due at least in part to the production of stem cell chemoattractants by the lungs and to humoral and physical interactions between stem cells and lung cells. We speculate that mobilization of this population of BMDMSCs may be a general mechanism for modulating an acute inflammatory response.

AB - Bone marrow-derived mesenchymal stem cells (BMDMSCs) appear to be important in repair of the chronic lung injury caused by bleomycin in mice. To determine effects of these BMDMSCs on an acute inflammatory response, we injected C57BL/6 mice intraperitoneally with 1 mg/kg endotoxin followed either by intravenous infusion of 5 × 105 BMDMSCs, the same number of lung fibroblasts, or an equal volume of normal saline solution. Lungs harvested 6, 24, and 48 h and 14 days after endotoxin showed that BMDMSC administration prevented endotoxin-induced lung inflammation, injury, and edema. Although we were able to detect donor cells in the lungs at 1 day after endotoxin, by 14 days no donor cells were detected. BMDMSC administration suppressed the endotoxin-induced increase in circulating proinflammatory cytokines without decreasing circulating levels of anti-inflammatory mediators. Ex vivo cocultures of BMDMSC and lung cells from endotoxemic animals demonstrated a bilateral conversation in which lung cells stimulated proliferation and migration of stem cells and suppressed proinflammatory cytokine production by lung cells. We conclude that BMDMSCs decrease both the systemic and local inflammatory responses induced by endotoxin. These effects do not require either lung engraftment or differentiation of the stem cells and are due at least in part to the production of stem cell chemoattractants by the lungs and to humoral and physical interactions between stem cells and lung cells. We speculate that mobilization of this population of BMDMSCs may be a general mechanism for modulating an acute inflammatory response.

KW - Lipopolysaccharide

KW - Lung injury

UR - http://www.scopus.com/inward/record.url?scp=34447511526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447511526&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00431.2006

DO - 10.1152/ajplung.00431.2006

M3 - Article

C2 - 17416739

AN - SCOPUS:34447511526

VL - 293

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 1

ER -